Treatment for hepatic encephalopathy: Tips from TIPS?

Journal of Hepatology

Volumn 42, Issue 5, 2005, Pages 626-628

  Morgan, Marsha Y ^a   Amodio, Piero ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DISACCHARIDE; LACTITOL; LACTULOSE; NEUROTOXIN; RIFAXIMIN; SORBITOL;

CLINICAL TRIAL; DRUG EFFICACY; EDITORIAL; HEMODYNAMICS; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; MORTALITY; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 17044363868     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.03.001     Document Type: Editorial

References (21)

1. Als-Nielsen B, Koretz RL, Kjaergard LL, Gluud C. Branched-chain amino acids for hepatic encephalopathy (Cochrane Review). In: The Cochrane Library, Issue 2, 2003. Chichester, UK: Wiley.
2. Liu JP, Gluud LL, Als-Nielsen B, Gluud C. Artificial and bioartificial support systems for liver failure (Cochrane Review). In: The Cochrane Library, Issue 1, 2004. Chichester, UK: Wiley.
3. Als-Nielsen B, Gluud LL, Gluud C. Benzodiazepine receptor antagonists for hepatic encephalopathy (Cochrane Review). In: The Cochrane Library, Issue 2, 2004. Chichester, UK: Wiley.
4. Als-Nielsen B, Gluud LL, Gluud C. Nonabsorbable disaccharides for hepatic encephalopathy (Cochrane Review). In: The Cochrane Library, Issue 2, 2004. Chichester, UK: Wiley.
5. Liu JP, Gluud LL, Als-Nielsen B, Gluud C. Dopaminergic agonists for hepatic encephalopathy (Cochrane Review). In: The Cochrane Library, Issue 4, 2004. Chichester, UK: Wiley.
6. L.L. Kjaergard, J. Liu, B. Als-Nielsen, and C. Gluud Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review JAMA 289 2003 217 222
7. B. Als-Nielsen, L.L. Gluud, and C. Gluud Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomized trials Br Med J 328 2004 1046 1050
8. S. Sherlock, W.H.J. Summerskill, L.P. White, and E.A. Phear Portal systemic encephalopathy Lancet 4 1954 453 457
9. D.L. Shawcross, and R. Jalan Treatment of hepatic encephalopathy: It's not lactulose Br Med J 329 2004 112
10. O. Riggio, A. Masini, C. Efrati, F. Nicolao, S. Angeloni, and F.M. Salvatori Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study J Hepatol 42 2005 674 679
11. Y. Mamiya, H. Kanazawa, Y. Kimura, Y. Narahara, Y. Yamate, and K. Nakatsuka Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt Hepatol Res 30 2004 162 168
12. O. Riggio, M. Merli, G. Pedretti, R. Servi, P. Meddi, and R. Lionetti Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Incidence and risk factors Dig Dis Sci 41 1996 578 584
13. O. Riggio, F. Nicolao, S. Angeloni, A. Masini, F. Salvatori, and F. Fanelli Intractable hepatic encephalopathy after tips with polytetrafluoroethylene-covered stent-graft Scand J Gastroenterol 38 2003 570 572
14. J.H. Cummings, and H.N. Englyst Gastrointestinal effects of food carbohydrate Am J Clin Nutr 61 1995 938S 945S
15. A. Vince, M. Killingley, and O.M. Wrong Effect of lactulose on ammonia production in a fecal incubation system Gastroenterology 74 1978 544 549
16. C.J. McClain, J.P. Kromhout, L. Zieve, and W.C. Duane Effect of sorbitol on psychomotor function: its use in alcoholic cirrhosis Arch Intern Med 141 1981 901 903
17. H.O. Conn, C.M. Leevy, Z.R. Vlahcevic, J.B. Rodgers, W.C. Maddrey, and L. Seeff Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial Gastroenterology 72 1977 573 583
18. C.E. Atterbury, W.C. Maddrey, and H.O. Conn Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial Am J Dig Dis 23 1978 398 406
19. K. Weissenborn, J.C. Ennen, H. Schomerus, N. Rückert, and H. Hecker Neuropsychological characterization of hepatic encephalopathy J Hepatol 34 2001 768 773
20. P. Amodio, S. Montagnese, A. Gatta, and M.Y. Morgan Characteristics of minimal hepatic encephalopathy Metab Brain Dis 19 2004 253 267
21. S. Montagnese, P. Amodio, and M.Y. Morgan Methods for diagnosing hepatic encephalopathy in patients with cirrhosis: a multidimensional approach Metab Brain Dis 19 2004 281 312